Please login to the form below

Not currently logged in
Email:
Password:

PureTech Health appoints chief scientific officer

Dr Joseph Bolen brings 30 years of clinical experience to the biotech

PureTech Health Dr Joseph BolenBoston, US-based PureTech Health has appointed Dr Joseph Bolen as its chief scientific officer.

Dr Bolen will be responsible for the scientific development and advancement of PureTech Health's pipeline, working with the company's scientific advisory board and R&D team.

Bringing over 30 years of clinical development experience to the role, he joins from Moderna Therapeutics where he most recently served as president and chief scientific officer.

Prior to this, Dr Bolen was chief scientific officer and global head of oncology research at Millennium, Takeda's oncology business, and has held senior R&D positions at Bristol-Myers Squibb, Hoechst Marion Roussel and Schering-Plough.

Daphne Zohar, chief executive officer of PureTech Health, said: “We are tremendously excited to bring Joe's visionary leadership and drug development expertise to PureTech.

“Joe is a seasoned industry expert who brings the ideal balance of rigor and creativity to the role of chief scientific officer, and shares our vision for identifying and nurturing innovation that can potentially redefine healthcare.”

4th November 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Downloadable Pack: Understanding Multiple Sclerosis
Inside this downloadable pack, you’ll find a wealth of exclusive information on the way multiple sclerosis is commonly treated today. As well as areas of continuous improvement for the industry....
Six factors that drive a multiple sclerosis patient's choice of disease-modifying therapy
MS advocate Trishna Bharadia explains the numerous factors that lead patients to choose a disease-modifying therapy, including the important considerations healthcare professionals and pharma often forget....
Innovative approaches in the treatment of multiple sclerosis
Blue Latitude Health Senior Associate Consultant Will Frostick delves into the MS treatment landscape and explores some of the cutting-edge treatments on the horizon....

Infographics